Cleared Traditional

K140547 - EXCERA FITRITE TOTAL HIP ARTHROPLASTY S...

K140547 is an FDA 510(k) clearance for EXCERA FITRITE TOTAL HIP ARTHROPLASTY S..., manufactured by Excera Orthopedics, Inc.. The device is a Class 2 Orthopedic device with product code LPH cleared through the Traditional 510(k) pathway after a 324-day FDA review.

K140547 · Excera Orthopedics, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2015
Decision
324d
Days
Class 2
Risk

K140547 is an FDA 510(k) clearance for the EXCERA FITRITE TOTAL HIP ARTHROPLASTY SYSTEM. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented (product code LPH), Class II - Special Controls.

Submitted by Excera Orthopedics, Inc. (Shelton, US). The FDA issued a Cleared decision on January 22, 2015 after a review of 324 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3358 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Excera Orthopedics, Inc. devices

FDA 510(k) Submission Details - K140547

510(k) Number K140547 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 04, 2014
Decision Date January 22, 2015
Days to Decision 324 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
202d slower than avg
Panel avg: 122d · This submission: 324d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LPH Device Classification - Class 2, Special Controls

Product Code LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3358
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LPH Prosthesis, Hip, Semi-constrained, Metal/polymer, Porous Uncemented

All 477
Devices cleared under the same product code (LPH) and FDA review panel - the closest regulatory comparables to K140547.
G7 Freedom and Offset Liners, Freedom Head, Size 32
K142882 · Biomet, Inc. · Feb 2015
Stryker Orthopaedics Acetabular Shells, Femoral Stems and Total Hip Instruments for use with the Direct Superior Approach
K143085 · Stryker Orthopaedics · Feb 2015
Trident® Tritanium® PST® Acetabular Shells
K142606 · Mako Surgical Corp. · Jan 2015
Echo Bi-Metric Microplasty Hip System
K143009 · Biomet, Inc. · Dec 2014
G7 OSSEOTI ACETUBLAR SHELLS
K140669 · Biomet, Inc. · Dec 2014
Restoration Anatomic Shell
K142462 · Stryker Orthopaedics · Nov 2014